YAP1 and hepatocellular carcinoma: Numerous papers implicate aberrant YAP/TAZ signaling with HCC development in vivo (Corvaisier et al. 2016; Kim et al. 2016, 127; Kim et al. 2018; Zhang et al. 2018; Moon et al. 2019; Van Haele et al. 2019; Weiler et al. 2020; Bisso et al. 2020).